Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 3,826 | 3,565 | 4,263 | 2,364 | 0 |
| Gross Profit | 3,826 | 3,565 | 4,263 | 2,364 | N/A |
| Operating Expenses | 98,479 | 8,198 | 10,036 | 6,835 | 7,787 |
| Operating Income | -94,653 | -4,633 | -5,773 | -4,471 | -7,787 |
| Other Income | 2,019 | 288 | 216 | 201 | 1 |
| Pre-tax Income | -92,634 | -4,345 | -5,557 | -4,270 | -7,786 |
| Net Income Continuous | -92,634 | -4,345 | -5,557 | -4,270 | -7,786 |
| Net Income | $-92,634 | $-4,345 | $-5,557 | $-4,270 | $-7,786 |
| EPS Basic Total Ops | -4.21 | -0.36 | -0.46 | -0.35 | -0.64 |
| EPS Basic Continuous Ops | -4.22 | -0.36 | -0.46 | -0.35 | -0.64 |
| EPS Diluted Total Ops | -4.21 | -0.36 | -0.46 | -0.35 | -0.64 |
| EPS Diluted Continuous Ops | -4.22 | -0.36 | -0.46 | -0.35 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.54 | -0.36 | -0.46 | -0.35 | -0.64 |
| EBITDA(a) | $-94,908 | $-4,467 | $-5,616 | $-4,323 | $-7,527 |